Mesenchymal stem cells as a potential therapeutic tool to cure cognitive impairment caused by neuroinflammation

doi:10.4252/wjsc.v13.i8.1072

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 8

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4025)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-1) series.

Item

Count

PDF

278

WORD

126

HTML

2094

Figures (1-1)

148

Tables (1-1)

166

Sum=2812

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

358

Download

855

Sum=1213

Aug 26, 2021 (publication date) through Apr 26, 2024

Times Cited of This Article

Times Cited (14)

Journal Information of This Article

Publication Name

World Journal of Stem Cells

ISSN

1948-0210

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Stem Cells. Aug 26, 2021; 13(8): 1072-1083
Published online Aug 26, 2021. doi: 10.4252/wjsc.v13.i8.1072

Open in New Tab Full Size Figure Download Figure

Figure 1 Scheme demonstrating the nicotinic acetylcholine receptors of α7 subtype involvement in the development of cognitive impairment upon neuroinflammation and positive effects of nicotinic acetylcholine receptors of α7 subtype-specific agonist PNU282987, N-stearoylethanolamine and mesenchymal stem cells. α7 nAChR: Nicotinic acetylcholine receptors of α7 subtype; LPS: Lipopolysaccharide; MSCs: Mesenchymal stem cells; NSE: N-stearoylethanolamine.

Citation: Skok M. Mesenchymal stem cells as a potential therapeutic tool to cure cognitive impairment caused by neuroinflammation. World J Stem Cells 2021; 13(8): 1072-1083
URL: https://www.wjgnet.com/1948-0210/full/v13/i8/1072.htm
DOI: https://dx.doi.org/10.4252/wjsc.v13.i8.1072